第三方網上售藥將被叫停? 天貓證實暫停藥品業務

Chinese e-commerce giant Alibaba Group has ceased online sales of medicines on its Tmall platform, citing changes in government regulation.

國內電商巨頭阿里巴巴集團近日宣稱，由於政府政策變化，已暫停旗下天貓平臺的網上售藥業務。

Tmall has received a notice from the China Food and Drug Administration's (CFDA) Hebei province branch, requiring "urgent control measures relating to drug products".

天貓收到了河北省食品藥品監督管理局的通知，要求對藥品類目採取緊急管控措施。

Tmall said in a statement it will cooperate and stop the online medicine retail business on the third-party platform.

天貓在聲明中表示，將配合停止第三方平臺藥品網上零售業務。

The new regulations come as a surprise as an increasing number of e-commerce companies plan to tap into the online sales of over-the-counter medicines. The CFDA did not elaborate on the reason why sales were halted.

由於越來越多的電商企業計劃進軍非處方藥網上銷售市場，這一新規的出臺頗爲出人意料。食品藥品監督管理局目前也並沒有詳細說明爲什麼藥物銷售被叫停。

An industrial insider, who refused to be named, said the regulation did not only apply to Tmall.

一位拒絕透露姓名的有業內人士表示，這一規定並不只適用於天貓。

Other e-commerce companiesinvolved in selling drugs on third-party platforms, such as , are expected to receive similar orders from local food and drug authorities.

從事第三方平臺藥品網上零售的其他電商企業，比如一號店，也將收到當地食藥監局的類似通知。